首页工具

登录

搜索结果

Search Results for " sglt2 "

39

抑制剂 & 化合物

5

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T9590	T-1095	SGLT; transporter	GPCR/G Protein; Metabolism
	T-1095 是一种口服有活性的Na+-葡萄糖协同转运蛋白选择性抑制剂，能够抑制 SGLT1 (IC50:22.8 µm) 及 SGLT2 (IC50:2.3 µm) 。它可用于研究糖尿病。
T2385	Ipragliflozin 伊格列净,ASP1941	SGLT	GPCR/G Protein
	Ipragliflozin (ASP1941) 是一种口服有效的，选择性的 SGLT2抑制剂，对人 SGLT2 和 SGLT1，大鼠 SGLT2 和 SGLT1，小鼠 SGLT2 和 SGLT1 的 IC50分别为 7.38 和 1876 nM，6.73 和 1166 nM，5.64 和 1380 nM。Ipragliflozin 具有抗糖尿病活性。
T4999	Ertugliflozin 埃格列净,MK-8835,PF-04971729	SGLT	GPCR/G Protein
	Ertugliflozin (PF-04971729) 是选择性的、口服有效的钠离子依赖的葡萄糖协同转运蛋白2 (SGLT2) 抑制剂，对h-SGLT2 的IC50值为 0.877 nM。Ertugliflozin 在2型糖尿病中有研究价值。
T1782	Canagliflozin 卡格列净,JNJ 24831754ZAE,JNJ 28431754AAA,TA 7284,JNJ 28431754	SGLT	GPCR/G Protein
	Canagliflozin (JNJ 28431754AAA) 是SGLT2的选择性抑制剂，在表达 mSGLT2，rSGLT2 和 hSGLT2 的 CHO 细胞上，IC50分别为 2 nM，3.7 nM 和 4.4 nM。
T34286	Remogliflozin etabonate GSK189075,GSK 189075,GSK-189075A,GSK189075A,GSK-189075,GSK 189075A	SGLT	GPCR/G Protein
	Remogliflozin etabonate (GSK189075A) 是 regaliflozin 的前药和 SGLT2 抑制剂，对 hSGLT2、rSGLT2、rSGLT1 和 hSGLT1 的 Ki 值分别为 1.95、2.14、8.57 和 43.1μM。
T2389	Dapagliflozin 达格列净,BMS-512148	SGLT; HIF	Angiogenesis; Chromatin/Epigenetic; GPCR/G Protein
	Dapagliflozin (BMS-512148) 竞争性的葡萄糖协同转运蛋白2 (SGLT2) 抑制剂，可促进尿液中葡萄糖的排泄，在糖尿病 (DM) 研究中具有价值。Dapagliflozin 诱导 HIF1表达并减轻肾脏 IR 损伤。
T4460	Dapagliflozin ((2S)-1,2-propanediol, hydrate) BMS-512148 (2S)-1,2-propanediol, hydrate,达格列净 (2S)-1,2-丙二醇水合物,Dapagliflozin propanediol monohydrate	SGLT	GPCR/G Protein
	Dapagliflozin ((2S)-1,2-propanediol, hydrate) (BMS-512148 (2S)-1,2-propanediol, hydrate) 是 Dapagliflozin 1,2-propanediol, hydrate 的 S 型异构体，是竞争性葡萄糖协同转运蛋白2 抑制剂，可促进尿液中葡萄糖的排泄，可用于糖尿病的研究。它诱导 HIF1表达并减轻肾脏 IR 损伤。
T67849	O-Desethyl Dapagliflozin Empagliflozin-4	SGLT	GPCR/G Protein
	O-Desethyl Dapagliflozin (Empagliflozin-4) 是一种 SGLT2 抑制剂, IC50=33nM.
T7217	Bexagliflozin THR-1442,EGT1442,EGT0001442	SGLT	GPCR/G Protein
	Bexagliflozin (EGT1442) 是一种选择性的，口服有效的钠葡萄糖协同转运蛋白-2 (SGLT2) 抑制剂，对人 SGLT2 和 SGLT1 作用的 IC50值分别为 2 nM 和 5.6 μM。EGT1442在 2 型糖尿病中有研究价值。
T5016	Tofogliflozin (hydrate) 托格列净,Tofogliflozin hydrate,CSG-452 hydrate	SGLT; Reactive Oxygen Species; ROS	GPCR/G Protein; Immunology/Inflammation; Metabolism; NF-κB
	Tofogliflozin hydrate (CSG-452 hydrate) 是一种有效的，选择性的 SGLT2抑制剂，IC50为 2.9 nM，对人、大鼠和小鼠 SGLT2的Ki 分别为 2.9 nM，14.9 nM 和 6.4 nM。Tofogliflozin hydrate 对肾小管细胞中高葡萄糖诱导的ROS 生成具有部分抑制作用。
T68174	Sergliflozin A	SGLT	GPCR/G Protein
	Sergliflozin A 是一种选择型SGLT2抑制剂，以剂量依赖性方式诱导糖尿。可降低高血糖。
T16083	Mizagliflozin GSK-1614235 free base,KGA-3235 free base,DSP-3235 free base	SGLT	GPCR/G Protein
	Mizagliflozin (GSK-1614235 free base) 是口服有效的、选择性的 SGLT1抑制剂，对人 SGLT1 的 Ki 值为 27 nM。Mizagliflozin 对 SGLT1 的选择性是 SGLT2的303 倍。它是抗糖尿病药物，可以改善餐后血糖波动。它在改善慢性便秘方面具有潜在的作用。
T3547	Sotagliflozin LX-4211,LP-802034	SGLT	GPCR/G Protein
	Sotagliflozin (LP-802034) 是有效的SGLT1/2抑制剂，用作抗糖尿病剂。
T28757	Sergliflozin etabonate GW-869682,GW-869682X,KGT-1251,GW869682X,GW869682,KGT1251	SGLT	GPCR/G Protein
	Sergliflozin etabonate (KGT-1251) 是一种 SGLT-2 抑制剂，可用于 2 型糖尿病和肥胖症的研究。
T15656	KGA-2727	SGLT	GPCR/G Protein
	KGA-2727是选择性，高亲和力和口服有效的 SGLT1抑制剂，对人和大鼠 SGLT1的 Ki 分别为 97.4 nM 和 43.5 nM，对 SGLT1的选择性比人SGLT2 高 140 倍，大鼠SGLT2高390 倍。KGA-2727具有抗糖尿病活性。
T1782L	Canagliflozin hemihydrate JNJ28431754,TA 7284,TA7284,TA-7284,JNJ 28431754,JNJ-28431754	SGLT	GPCR/G Protein
	Canagliflozin hemihydrate (TA 7284) (JNJ28431754 hemihydrate) 是一种选择性的 SGLT2 抑制剂，作用于表达 mSGLT2，rSGLT2 和 hSGLT2 的 CHO 细胞，IC50 分别为 2 nM，3.7 nM 和 4.4 nM。
T15244	Ertugliflozin L-pyroglutamic acid 埃格列净,PF-04971729 L-pyroglutamic acid	Others; SGLT	GPCR/G Protein; Others
	Ertugliflozin L-pyroglutamic acid (PF-04971729 L-pyroglutamic acid) 是一种特异性和口服活性的 hSGLT2 抑制剂，IC50 为 0.877 nM。 Ertugliflozin L-pyroglutamic acid 可用于治疗 2 型糖尿病的研究。
T1766	Empagliflozin BI 10773,恩格列净	SGLT	GPCR/G Protein
	Empagliflozin (BI 10773) 是一种 SGLT-2 抑制剂 (IC50=3.1 nM)，具有有效的和选择性，对 SGLT-1/4/5/6 的选择性高 300 倍以上。Empagliflozin 可用于治疗二型糖尿病。
T15505	HSK0935 HSK 0935,HSK-0935	SGLT	GPCR/G Protein
	HSK0935 is a highly selective and orally available SGLT2 inhibitor (IC50: 1.3 nM). It has antihyperglycemic activities.
T38539	Luseogliflozin hydrate 鲁格列净水合物,TS 071 hydrate
	Luseogliflozin (TS 071) hydrate, a second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor, exhibits selective potency and oral activity, with an IC50 of 2.26 nM. This compound is utilized in research for the treatment of type 2 diabetes mellitus (T2DM).
T21399	Luseogliflozin TS71,TS-071,TS 71,TS071,TS-71,TS 071
	Luseogliflozin, a potent and competitive inhibitor of sodium-dependent glucose cotransporter 2 (SGLT2), competitively inhibits human SGLT2-mediated glucose uptake with a Ki value of 1.10 nM.
T32058	Henagliflozin SHR3824,SHR 3824,SHR-3824
	Henagliflozin (SHR3824) is an effective, oral, and selective SGLT2 inhibitor that effectively inhibits human SGLT2 in vitro, but has very weak inhibitory effects on human SGLT1.
T13179	Tofogliflozin CSG452	Others	Others
	Tofogliflozin is a highly specific inhibitor of sodium/glucose cotransporter 2 (SGLT2) (Kis: 2.9, 14.9, and 6.4 nM for human, rat, and mouse SGLT2. IC50s: 2.9/14.9/6.4 nM (human/rat/mouse SGLT2)).
T15752	Licogliflozin LIK066	SGLT	GPCR/G Protein
	Licogliflozin (LIK066) 是钠-葡萄糖协同转运蛋白 (SGLT1和SGLT2) 的有效抑制剂。
T3450	LX4211 N-4 Intermediate 9 索格列净中间体9,Sotagliflozin Intermediate 9
	LX4211 N-4 Intermediate 9 是 Sotagliflozin 的中间体，Sotagliflozin 是一种口服生物可利用的 SGLT1 和 SGLT2 抑制剂。
T11667	Ipragliflozin (L-Proline) Ipragliflozin L-Proline	Others	Others
	Ipragliflozin is a highly potent and selective SGLT2 inhibitor with an IC50 of 2.8 nM; little and NO potency for SGLT1/3/4/5/6.
T10669	Canagliflozin-d4 Canagliflozin D4	Others	Others
	Canagliflozin D4 is a deuterium-labeled Canagliflozin. Canagliflozin is an SGLT2 inhibitor.
T39966	SGLT1/2-IN-2 SGLT1/2-IN-2
	SGLT1/2-IN-2 is a chemical compound with robust dual inhibitory properties, exhibiting potent activities against SGLT1 (IC50 = 96 nM) and SGLT2 (IC50 = 1.3 nM).
T15797	LX2761	Others	Others
	LX2761 is a chemically stable and effective inhibitor against sodium-dependent glucose cotransporter 1 (SGLT1) and SGLT2 (IC50s: 2.2 nM and 2.7nM for hSGLT1 and hSGLT2). However, it shows specific SGLT1 inhibition in the gastrointestinal (GI) tract.
T72143	Velagliflozin proline hydrate
	Velagliflozin proline hydrate 是 Velagliflozin 的临床形式。Velagliflozin 是一种可口服的钠-葡萄糖协同转运蛋白 2 (SGLT2) 抑制剂，具有抗糖尿病的活性。特别是，Velagliflozin 减少肾葡萄糖重吸收，促进葡萄糖尿，从而降低血糖和胰岛素浓度。
T30534	BMS-639432
	BMS-639432 is a potent sodium-glucose cotransporter type II (SGLT2) inhibitor.
T35619	Dapagliflozin-3-O-β-D-Glucuronide
	Dapagliflozin-3-O-β-D-glucuronide is a metabolite of dapagliflozin . Dapagliflozin is a first generation selective sodium glucose cotransporter (SGLT) 2 inhibitor that blocks glucose transport.[1] Dapagliflozin is metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A9 to dapagliflozin-3-O-β-D-glucuronide, which is 2,600-fold less potent than the parent compound with regard to SGLT2 inhibition.[2]
T62830	SGLT1/2-IN-1
	SGLT1/2-IN-1 是一种 SGLT1/SGLT2 双重抑制剂.
T24708	Remogliflozin GSK189074,Remogliflozin A,GSK-189074,GSK 189074
	Remogliflozin is an effective sodium-glucose transporter 2 inhibitor (Kis = 12.4 and 26 nM for human and rat SGLT2, respectively).
T70390	YM-543 choline
	YM-543, also known as ASP-543, is a selective SGLT2 inhibitor. Sodium-glucose cotransporter 2 (SGLT2) is a specifically expressed transporter in the kidney that plays an important role in renal glucose reabsorption, and its inhibition may present a novel therapeutic strategy for treating diabetes. YM543 potently and selectively inhibited mouse and human SGLT2 activities at nanomolar ranges. In vivo single oral administration of YM543 dose-dependently and significantly reduced blood glucose level...
T10958	Dapagliflozin-d5 BMS-512148 D5	Others	Others
	Dapagliflozin D5 (BMS-512148 D5) is deuterated Dapagliflozin. Dapagliflozin is a competitive SGLT2 inhibitor.
T34767	TA-1887 TA 1887,TA1887
	TA-1887 is a new type of selective inhibitor of sglt2 for the treatment of type 2 diabetes. It has a significant hypoglycemic effect in KK (HF-KK) mice fed a high-fat diet. TA-1887 has good pharmacokinetic characteristics and significantly increases UGE
T12892	SGL5213	SGLT	GPCR/G Protein
	SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes.
T12893	SGLT inhibitor-1	SGLT	GPCR/G Protein
	SGLT inhibitor-1 is a potentsodium glucose co-transporter proteins (SGLTs) dual inhibitor(hSGLT1 and hSGLT2 with IC50s of 43 nM and 9 nM, respectively).

化合物

Cat.No: T9590

Target: SGLT, transporter

Cat.No: T2385

Synonym: 伊格列净,ASP1941

Target: SGLT

Cat.No: T4999

Synonym: 埃格列净,MK-8835,PF-04971729

Target: SGLT

Cat.No: T1782

Synonym: 卡格列净,JNJ 24831754ZAE,JNJ 28431754AAA,TA 7284,JNJ 28431754

Target: SGLT

Remogliflozin etabonate

Cat.No: T34286

Synonym: GSK189075,GSK 189075,GSK-189075A,GSK189075A,GSK-189075,GSK 189075A

Target: SGLT

Cat.No: T2389

Synonym: 达格列净,BMS-512148

Target: SGLT, HIF

Dapagliflozin ((2S)-1,2-propanediol, hydrate)

Cat.No: T4460

Synonym: BMS-512148 (2S)-1,2-propanediol, hydrate,达格列净 (2S)-1,2-丙二醇水合物,Dapagliflozin propanediol monohydrate

Target: SGLT

O-Desethyl Dapagliflozin

Cat.No: T67849

Synonym: Empagliflozin-4

Target: SGLT

Cat.No: T7217

Synonym: THR-1442,EGT1442,EGT0001442

Target: SGLT

Tofogliflozin (hydrate)

Cat.No: T5016

Synonym: 托格列净,Tofogliflozin hydrate,CSG-452 hydrate

Target: SGLT, Reactive Oxygen Species, ROS

Cat.No: T68174

Target: SGLT

Cat.No: T16083

Synonym: GSK-1614235 free base,KGA-3235 free base,DSP-3235 free base

Target: SGLT

Cat.No: T3547

Synonym: LX-4211,LP-802034

Target: SGLT

Sergliflozin etabonate

Cat.No: T28757

Synonym: GW-869682,GW-869682X,KGT-1251,GW869682X,GW869682,KGT1251

Target: SGLT

Cat.No: T15656

Target: SGLT

Canagliflozin hemihydrate

Cat.No: T1782L

Synonym: JNJ28431754,TA 7284,TA7284,TA-7284,JNJ 28431754,JNJ-28431754

Target: SGLT

Ertugliflozin L-pyroglutamic acid

Cat.No: T15244

Synonym: 埃格列净,PF-04971729 L-pyroglutamic acid

Target: Others, SGLT

Cat.No: T1766

Synonym: BI 10773,恩格列净

Target: SGLT

Cat.No: T15505

Synonym: HSK 0935,HSK-0935

Target: SGLT

Luseogliflozin hydrate

Cat.No: T38539

Synonym: 鲁格列净水合物,TS 071 hydrate

Cat.No: T21399

Synonym: TS71,TS-071,TS 71,TS071,TS-71,TS 071

Cat.No: T32058

Synonym: SHR3824,SHR 3824,SHR-3824

Cat.No: T13179

Synonym: CSG452

Target: Others

Cat.No: T15752

Synonym: LIK066

Target: SGLT

LX4211 N-4 Intermediate 9

Cat.No: T3450

Synonym: 索格列净中间体9,Sotagliflozin Intermediate 9

Ipragliflozin (L-Proline)

Cat.No: T11667

Synonym: Ipragliflozin L-Proline

Target: Others

Canagliflozin-d4

Cat.No: T10669

Synonym: Canagliflozin D4

Target: Others

Cat.No: T39966

Synonym: SGLT1/2-IN-2

Cat.No: T15797

Target: Others

Velagliflozin proline hydrate

Cat.No: T72143

Cat.No: T30534

Dapagliflozin-3-O-β-D-Glucuronide

Cat.No: T35619

Cat.No: T62830

Cat.No: T24708

Synonym: GSK189074,Remogliflozin A,GSK-189074,GSK 189074

Cat.No: T70390

Dapagliflozin-d5

Cat.No: T10958

Synonym: BMS-512148 D5

Target: Others

Cat.No: T34767

Synonym: TA 1887,TA1887

Cat.No: T12892

Target: SGLT

SGLT inhibitor-1

Cat.No: T12893

Target: SGLT

Cat. No.	Product Name	Target	Signaling Pathways
TN1847	Kushenol X 苦参醇X	Others	Others
	Kushenol X exhibits inhibitory activity against Sodium-dependent glucose cotransporter 2(SGLT2).
TN1841	Kushenol A 苦参新醇 A,Leachianone E	cAMP	GPCR/G Protein
	Kushenol A is a kind of Adenosine 3', 5'-cyclic monophosphate(cAMP)phosphodiesterase inhibitiors, it shows selective alpha-glucosidase inhibitory activity. Kushenol A and kushenol C exhibit inhibitory activity against Sodium-dependent glucose cotransporter 2(SGLT2).
T2922	Phlorizin Floridzin,根皮甙,根皮苷,NSC 2833,Phloridzin	ATPase; SGLT	GPCR/G Protein; Membrane transporter/Ion channel
	Phlorizin (Phloridzin) 是非选择性的SGLT 抑制剂，也是Na+/K+-ATPase 抑制剂，对于hSGLT1和hSGLT2的Ki 值分别为 300 和 39 nM。
TN1842	Kushenol I	GABA Receptor; Antifection	Membrane transporter/Ion channel; Microbiology/Virology; Neuroscience
	Kushenol I is a GABAA receptor modulator, it exhibits inhibitory activity against Sodium-dependent glucose cotransporter 2(SGLT2).Kushenol I is shown to be active against the plant pathogenic fungus Cladosporium cucumerinum.
TN4399	Kushenol C	SGLT; NF-κB; ROS; BACE; Antifection	GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Neuroscience; NF-κB
	Kushenol C is a good 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenger, and it exhibits inhibitory activity against Sodium-dependent glucose cotransporter 2(SGLT2). Kushenol C shows antimicrobial activity against Staphylococcus aureus and Streptococcus mutan

天然产物

Cat.No: TN1847

Synonym: 苦参醇X

Target: Others

Cat.No: TN1841

Synonym: 苦参新醇 A,Leachianone E

Target: cAMP

Cat.No: T2922

Synonym: Floridzin,根皮甙,根皮苷,NSC 2833,Phloridzin

Target: ATPase, SGLT

Cat.No: TN1842

Target: GABA Receptor, Antifection

Cat.No: TN4399

Target: SGLT, NF-κB, ROS, BACE, Antifection

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼